Engineered Nanoparticles for Cancer Vaccination and Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Engineered Nanoparticles for Cancer Vaccination and Immunotherapy

Published:2020-10-05 Issue:10 Volume:53 Page:2094-2105
ISSN:0001-4842
Container-title:Accounts of Chemical Research
language:en
Short-container-title:Acc. Chem. Res.

Author:

Aikins Marisa E.¹²,Xu Cheng¹²^ORCID,Moon James J.¹²³^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan 48109, United States

2. Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan 48109, United States

3. Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48109, United States

Funder

National Cancer Institute

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute of Allergy and Infectious Diseases

Publisher

American Chemical Society (ACS)

Subject

General Medicine,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.accounts.0c00456

Reference69 articles.

1. Designer vaccine nanodiscs for personalized cancer immunotherapy

2. Efficient Lymph Node-Targeted Delivery of Personalized Cancer Vaccines with Reactive Oxygen Species-Inducing Reduced Graphene Oxide Nanosheets

3. Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer

4. Positron Emission Tomography-Guided Photodynamic Therapy with Biodegradable Mesoporous Silica Nanoparticles for Personalized Cancer Immunotherapy

5. Elimination of established tumors with nanodisc-based combination chemoimmunotherapy

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-dimensional nano-biomaterials in regulating the tumor microenvironment for immunotherapy;Nano TransMed;2024-12

2. Tumor associated antigens combined with carbon dots for inducing durable antitumor immunity;Journal of Colloid and Interface Science;2024-11

3. IL-22: A key inflammatory mediator as a biomarker and potential therapeutic target for lung cancer;Heliyon;2024-09

4. Stimuli-Responsive Nanomaterials for Tumor Immunotherapy;ACS Biomaterials Science & Engineering;2024-08-22

5. SERS surgical navigation with postsurgical immunotherapy of local microtumors and distant metastases for improved anticancer outcomes;Science Advances;2024-08-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3